Coronavirus

2020 Harrington Coronavirus Scholars

Michael Barry, PhD

Michael Barry, PhD

Mayo Clinic

Novel Vaccine Against COVID-19

Katherine Fitzgerald, PhD

Katherine Fitzgerald, PhD

University of Massachusetts

Fumarate Based Therapeutics and Clinical Trial for Lung Injury

Benjamin Gaston, MD

Benjamin Gaston, MD

Indiana University

Novel Agent to Accelerate Ventilator Weaning for Patient’s With COVID-19 Lung Infection

Jeffrey S. Glenn, MD, PhD

Jeffrey S. Glenn, MD, PhD

Stanford University

Single Dose Antiviral Therapeutic for COVID-19

Anastasia Khvorova, PhD

Anastasia Khvorova, PhD

University of Massachusetts

Multi-Virus Therapy for COVID-19 and Other Pandemic-Causing Viruses

Yulia Komarova, PhD

Yulia Komarova, PhD

University of Illinois

Novel Therapy for Acute Respiratory Distress

Anne Moscona, MD

Anne Moscona, MD

Columbia University

Intranasal Agent to Block COVID-19 Infection

Michel Nussenzweig, MD, PhD

Michel Nussenzweig, MD, PhD

The Rockefeller University

Human Antibodies to Prevent and Treat COVID-19

James Reynolds, PhD

James Reynolds, PhD

University Hospitals of Cleveland / Case Western Reserve University

First Multipurpose Drug to Improve Lung and Heart Function in COVID-19 Patients

Joseph Vinetz, MD

Joseph Vinetz, MD

Yale University

Antiviral Clinical Effects of Camostat Mesylate in Early COVID-19+ Outpatients

James Wells, PhD

James Wells, PhD

University of California, San Francisco

Novel Multi-Target Antibodies for COVID-19 Infection

James Wilson, MD, PhD

James Wilson, MD, PhD

University of Pennsylvania

Novel Intranasal Vaccine Alternative for COVID-19 Prophylaxis

The Harrington Project for Discovery & Development

Discover
Advance
Commercialize
Breakthrough Medicine